These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38364489)

  • 1. In vivo chronic scaffolding force of a resorbable magnesium scaffold.
    Forkmann C; Pritsch M; Baumann-Zumstein P; Lootz D; Joner M
    J Biomech; 2024 Feb; 164():111988. PubMed ID: 38364489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study.
    Hideo-Kajita A; Garcia-Garcia HM; Haude M; Joner M; Koolen J; Ince H; Abizaid A; Toelg R; Lemos PA; von Birgelen C; Christiansen EH; Wijns W; Neumann FJ; Kaiser C; Eeckhout E; Teik LS; Escaned J; Azizi V; Kuku KO; Ozaki Y; Dan K; Waksman R
    Cardiovasc Revasc Med; 2019 May; 20(5):392-398. PubMed ID: 31079817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SICI-GISE Position Document on the Use of the Magmaris Resorbable Magnesium Scaffold in Clinical Practice.
    Galli S; Testa L; Montorsi P; Bedogni F; Pisano F; Palloshi A; Mauro C; Contarini M; Varbella F; Esposito G; Caramanno G; Secco GG; D'Amico G; Musumeci G; Tarantini G
    Cardiovasc Revasc Med; 2022 Jan; 34():11-16. PubMed ID: 33674219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magmaris resorbable magnesium scaffold for the treatment of coronary heart disease: overview of its safety and efficacy.
    Bennett J; De Hemptinne Q; McCutcheon K
    Expert Rev Med Devices; 2019 Sep; 16(9):757-769. PubMed ID: 31345074
    [No Abstract]   [Full Text] [Related]  

  • 5. Magmaris Resorbable Magnesium Scaffold Versus Conventional Drug-Eluting Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity-Score-Matching Comparison.
    de Hemptinne Q; Xaplanteris P; Guédès A; Demeure F; Vandeloo B; Dugauquier C; Picard F; Warne DW; Pilgrim T; Iglesias JF; Bennett J
    Cardiovasc Revasc Med; 2022 Oct; 43():28-35. PubMed ID: 35641364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [SICI-GISE Position paper on the use of the magnesium bioresorbable scaffold Magmaris in clinical practice].
    Galli S; Testa L; Montorsi P; Bedogni F; Pisano F; Palloshi A; Mauro C; Contarini M; Varbella F; Esposito G; Caramanno G; Secco GG; D'Amico G; Musumeci G; Tarantini G
    G Ital Cardiol (Rome); 2020 Feb; 21(2 Suppl 1):52S-59S. PubMed ID: 32134409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bioresorbable magnesium scaffold (Magmaris)-State of the art: From basic concept to clinical application.
    Rola P; Włodarczak S; Doroszko A; Lesiak M; Włodarczak A
    Catheter Cardiovasc Interv; 2022 Nov; 100(6):1051-1058. PubMed ID: 36229949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Side-Branch Dilation Techniques After Resorbable Magnesium Scaffold Implantation: A Bench Study.
    de Pommereau A; Mogi S; de Hemptinne Q; Adjedj J; Varenne O; Picard F
    J Invasive Cardiol; 2019 Aug; 31(8):E249-E255. PubMed ID: 31368896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of a novel bioresorbable magnesium scaffold with different surface modifications.
    Menze R; Wittchow E
    J Biomed Mater Res B Appl Biomater; 2021 Sep; 109(9):1292-1302. PubMed ID: 33386677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Resorbable Magnesium Scaffold Magmaris in Acute Coronary Syndrome: An Appraisal of Evidence and User Group Guidance.
    Bennett J; Ielasi A; Torzewski J; de Hemptinne Q; Cerrato E; Lanocha M; Galli S; Sabaté M
    Cardiovasc Revasc Med; 2022 Jun; 39():106-113. PubMed ID: 34629285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A word of caution: Early failure of Magmaris® bioresorbable stent after pulmonary artery stenting.
    Haddad RN; Adel Hassan A; Al Soufi M; Kasem M
    Catheter Cardiovasc Interv; 2023 Jan; 101(1):131-134. PubMed ID: 36413609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Eluting Resorbable Magnesium Scaffold Implantation in ST-Segment Elevation Myocardial Infarction: A Pilot Study.
    de Hemptinne Q; Picard F; Briki R; Awada A; Silance PG; Dolatabadi D; Debbas N; Unger P
    J Invasive Cardiol; 2018 Jun; 30(6):202-206. PubMed ID: 29656279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds.
    Seguchi M; Baumann-Zumstein P; Fubel A; Waksman R; Haude M; Galli S; Joner M
    EuroIntervention; 2023 Jun; 19(2):e167-e175. PubMed ID: 36636768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery model.
    Waksman R; Zumstein P; Pritsch M; Wittchow E; Haude M; Lapointe-Corriveau C; Leclerc G; Joner M
    EuroIntervention; 2017 Jul; 13(4):440-449. PubMed ID: 28262623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium versus poly-L-lactic acid bioresorbable scaffolds: in vivo optical coherence tomography comparison of mechanical performance.
    Abellás-Sequeiros RA; Ocaranza-Sanchez R; Galvaõ-Braga C; Marques J; Gonzalez-Juanatey C
    Arch Cardiol Mex; 2020; 90(1):8-15. PubMed ID: 31996867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The coronary resorbable magnesium scaffold Magmaris®: what we have learnt (so far…).
    Bennett J; McCUTCHEON K
    Minerva Cardiol Angiol; 2021 Apr; 69(2):215-221. PubMed ID: 32326679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained Safety and Efficacy of Magnesium Reabsorbable Scaffold: 2-Year Follow-Up Analysis From First Magmaris Multicenter Italian Registry.
    Galli S; Troiano S; Palloshi A; Rapetto C; Pisano F; Aprigliano G; Leoncini M; Ravagnani P; Del Maestro M; Montorsi P
    Cardiovasc Revasc Med; 2022 Aug; 41():69-75. PubMed ID: 35256294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold.
    Tovar Forero MN; van Zandvoort L; Masdjedi K; Diletti R; Wilschut J; de Jaegere PP; Zijlstra F; Van Mieghem NM; Daemen J
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):226-231. PubMed ID: 31033171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-Generation Drug-Eluting Resorbable Magnesium Scaffold: Review of the Clinical Evidence.
    Ozaki Y; Garcia-Garcia HM; Shlofmitz E; Hideo-Kajita A; Waksman R
    Cardiovasc Revasc Med; 2020 Jan; 21(1):127-136. PubMed ID: 31662277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Procedural Technique on Cardiovascular Outcomes Following Second-Generation Drug-Eluting Resorbable Magnesium Scaffold Implantation.
    Ozaki Y; Garcia-Garcia HM; Melaku GD; Joner M; Galli S; Verheye S; Lee MKY; Waksman R; Haude M
    Cardiovasc Revasc Med; 2021 Aug; 29():1-6. PubMed ID: 34049817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.